[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fM18-kutJdRIulxyCuFr3kFyNPxAKYh9qqqt8LQHV2zk":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":33,"type":34},[],"2024-03-24 18:57:09",135410205,[8,9,10,11,12],"1~3周左右","2~12周左右","3~12周左右","3~10周左右","2~10周左右",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},15,"91d3c35551a2eb0f8d717e3272bf37b1","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F1b05d4c7470b5eb32ed98bafe78b7bc1.jpg","临床药理学（临床医学专业）","work_33043951","总论作业2-2024","妊娠多少周内药物致畸最敏感( )",[22,35,45,55,65,75,85,95,105,115],{"answer":23,"createTime":24,"id":25,"options":26,"question":32,"source":33,"type":34},[],"2024-03-24 18:57:08",135410182,[27,28,29,30,31],"药物预防、治疗疾病的理论和方法","药物与生命体之间相互作用机制合规律","药物和人体之间相互作用及规律","人体对药物的处置过程","药物对人体的治疗作用","临床药理学是研究( )","v1",0,{"answer":36,"createTime":24,"id":37,"options":38,"question":44,"source":33,"type":34},[],135410185,[39,40,41,42,43],"以动物为实验对象,研究新药的药效学、药动学及毒性","研究药物剂型因素、生物因素与药效之间的关系","在患者或健康志愿者中进行的试验药品的系统性研究","已批准上市的药品,对其安全有效性及费用等做出科学评估","以人为实验对象,研究新药的药效学、药动学及毒性","市场再评价是指( )",{"answer":46,"createTime":5,"id":47,"options":48,"question":54,"source":33,"type":34},[],135410187,[49,50,51,52,53],"安慰剂在临床药理研究中无实际的意义","临床试验中应设立双盲法","临床试验中的单盲法指对医生保密,对病人不保密","安慰剂在试验中不会引起不良反应","新药的随机对照试验都必须使用安慰剂","以下正确的描述是( )",{"answer":56,"createTime":5,"id":57,"options":58,"question":64,"source":33,"type":34},[],135410189,[59,60,61,62,63],"对照","随意","随机","盲法试验","安慰剂","临床试验方法中,不包括 ( )",{"answer":66,"createTime":5,"id":67,"options":68,"question":74,"source":33,"type":34},[],135410191,[69,70,71,72,73],"研究人对新药的耐受程度","研究动物及人对新药的耐受程度以及新药在机体内的药物代谢动力学过程","推荐临床给药剂量","确定临床给药方案","观察出现的各种不良反应","新药临床期Ⅰ试验的目的是( )",{"answer":76,"createTime":5,"id":77,"options":78,"question":84,"source":33,"type":34},[],135410193,[79,80,81,82,83],"AUC、Css、Vd","AUC、Tmax、Cmax","Tmax、Cmax、Vd","AUC、Tmax、Css","Cmax、Vd、Css","生物利用度检验的3个重要参数是 ( )",{"answer":86,"createTime":5,"id":87,"options":88,"question":94,"source":33,"type":34},[],135410196,[89,90,91,92,93],"病人是否使用了适用其病症的合适药物","血药浓度与药效间的关系是否适用于病情","药物对于此类病症的有效范围是否很窄","疗程长短是否能使病人在治疗期间受益于TDM","血药浓度测定的结果是否会显著改变临床决策并提供更多的信息","关于是否进行TDM的原则的描述错误的是(",{"answer":96,"createTime":5,"id":97,"options":98,"question":104,"source":33,"type":34},[],135410199,[99,100,101,102,103],"1.0ng\u002Fml","1.5ng\u002Fml","2.0ng\u002Fml","3.0ng\u002Fml","2.5ng\u002Fml","地高辛药物浓度超过多少应考虑是否药物中毒( )",{"answer":106,"createTime":5,"id":107,"options":108,"question":114,"source":33,"type":34},[],135410202,[109,110,111,112,113],"茶碱、苯妥英钠","地高辛、丙戊酸钠","茶碱、地高辛","丙戊酸、苯妥英钠","安定、茶碱","哪两个药物具有非线性药代动力学特征( )",{"answer":116,"createTime":5,"id":6,"options":117,"question":20,"source":33,"type":34},[],[8,9,10,11,12]]